Edition:
United States

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

6.90USD
20 Sep 2018
Change (% chg)

-- (--)
Prev Close
$6.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
158,676
52-wk High
$29.02
52-wk Low
$6.30

Chart for

About

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company. The Company is engaged in transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on... (more)

Overall

Beta: --
Market Cap(Mil.): $225.13
Shares Outstanding(Mil.): 32.63
Dividend: --
Yield (%): --

Financials

  JNCE.OQ Industry Sector
P/E (TTM): -- 107.68 32.65
EPS (TTM): -0.96 -- --
ROI: -14.00 1.61 12.72
ROE: -21.77 0.32 14.84

BRIEF-Jounce Therapeutics Q1 Shr Loss $0.40

* JOUNCE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 09 2018

BRIEF-Jounce Therapeutics Reports Q1 Loss Per Share Of $0.40

* JOUNCE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 09 2018

Earnings vs. Estimates